☰

David Vlahov - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Epidemiology
Tree Info Similar researchers PubMed Report error

445 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Eger WH, Altice FL, Lee J, Vlahov D, Khati A, Osborne S, Wickersham JA, Bohonnon T, Powell L, Shrestha R. Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder. Harm Reduction Journal. 19: 120. PMID 36307817 DOI: 10.1186/s12954-022-00703-8  0.315
2022 Khati A, Altice FL, Vlahov D, Eger WH, Lee J, Bohonnon T, Wickersham JA, Maviglia F, Copenhaver N, Shrestha R. Nurse Practitioner-Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial. Jmir Research Protocols. 11: e42585. PMID 36222826 DOI: 10.2196/42585  0.372
2022 Smith A, Breazeale S, Goulet JL, Vlahov D, Justice AC, Womack JA. A Systematic Review of Risk Factors for Suicide Among Persons Living with HIV (1996-2020). Aids and Behavior. PMID 35107660 DOI: 10.1007/s10461-022-03591-y  0.312
2021 Shevchenko AK, Zhernakova DV, Malov SV, Komissarov A, Kolchanova SM, Tamazian G, Antonik A, Cherkasov N, Kliver S, Turenko A, Rotkevich M, Evsyukov I, Vlahov D, Thami PK, Gaseitsiwe S, et al. Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34782459 DOI: 10.1073/pnas.2107830118  0.3
2019 Genberg BL, Kirk GD, Astemborski J, Lee H, Galai N, Nelson KE, Vlahov D, Celentano DD, Mehta SH. Durable Viral Suppression Among People Living with HIV who Inject Drugs from a Community-Based Cohort in Baltimore, Maryland, 1997-2017. American Journal of Epidemiology. PMID 31742591 DOI: 10.1093/Aje/Kwz258  0.359
2018 Cheung R, Hoffman RS, Vlahov D, Manini AF. Prognostic Utility of Initial Lactate in Patients With Acute Drug Overdose: A Validation Cohort. Annals of Emergency Medicine. PMID 29628190 DOI: 10.1016/J.Annemergmed.2018.02.022  0.323
2017 Manini AF, Nair AP, Vedanthan R, Vlahov D, Hoffman RS. Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose. Journal of the American Heart Association. 6. PMID 28159815 DOI: 10.1161/Jaha.116.004320  0.338
2016 Asher AK, Portillo CJ, Cooper BA, Dawson-Rose C, Vlahov D, Page KA. Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs. Substance Use & Misuse. 1-6. PMID 27219274 DOI: 10.3109/10826084.2016.1161054  0.349
2015 Lewis CF, Rivera AV, Crawford ND, Gordon K, White K, Vlahov D, Galea S. Individual and Neighborhood Characteristics Associated with HIV Among Black and Latino Adults Who Use Drugs and Unaware of Their HIV-Positive Status, New York City, 2000-2004. Journal of Racial and Ethnic Health Disparities. PMID 27294761 DOI: 10.1007/S40615-015-0176-X  0.482
2015 Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. Feasibility, acceptability and tolerability of targeted naltrexone for non-dependent methamphetamine-using and binge-drinking men who have sex with men. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26674372 DOI: 10.1097/Qai.0000000000000922  0.327
2015 Manini AF, Stimmel B, Hoffman RS, Vlahov D. Utility of Cardiac Troponin to Predict Drug Overdose Mortality. Cardiovascular Toxicology. PMID 26541348 DOI: 10.1007/S12012-015-9345-8  0.313
2015 Todd CS, Nasir A, Stanekzai MR, Fiekert K, Sipsma HL, Vlahov D, Strathdee SA. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan. Harm Reduction Journal. 12: 22. PMID 26472126 DOI: 10.1186/S12954-015-0056-Z  0.491
2015 Todd CS, Nasir A, Stanekzai MR, Fiekert K, Sipsma HL, Strathdee SA, Vlahov D. Impact of conflict and displacement on risk behaviours amongst people who inject drugs in Kabul, Afghanistan. The International Journal On Drug Policy. PMID 26303577 DOI: 10.1016/J.Drugpo.2015.07.014  0.308
2015 Ompad DC, Benjamin EO, Weiss L, Palamar JJ, Galea S, Wang J, Vlahov D. The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 92: 955-65. PMID 26215650 DOI: 10.1007/S11524-015-9973-0  0.337
2015 Manini AF, Hoffman RS, Stimmel B, Vlahov D. Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 22: 499-507. PMID 25903997 DOI: 10.1111/Acem.12658  0.315
2015 Genberg BL, Astemborski J, Vlahov D, Kirk GD, Mehta SH. Incarceration and injection drug use in Baltimore, Maryland. Addiction (Abingdon, England). 110: 1152-9. PMID 25845621 DOI: 10.1111/Add.12938  0.384
2014 Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, Vlahov D, Plankey MW. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 508-13. PMID 25271387 DOI: 10.1097/Qai.0000000000000364  0.36
2014 Weiss L, Gass J, Egan JE, Ompad DC, Trezza C, Vlahov D. Understanding prolonged cessation from heroin use: findings from a community-based sample. Journal of Psychoactive Drugs. 46: 123-32. PMID 25052788 DOI: 10.1080/02791072.2014.890765  0.322
2014 Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. Journal of Electrocardiology. 47: 244-50. PMID 24438862 DOI: 10.1016/J.Jelectrocard.2013.12.002  0.327
2013 Genberg BL, Gillespie M, Schuster CR, Johanson CE, Astemborski J, Kirk GD, Vlahov D, Mehta SH. Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addictive Behaviors. 38: 2868-73. PMID 24018232 DOI: 10.1016/J.Addbeh.2013.08.008  0.411
2013 Manini A, Jacobs M, Vlahov D, Hurd Y. On the role of genetic testing for personalized drug overdose management. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology. 9: 294-5. PMID 23860728 DOI: 10.1007/S13181-013-0318-7  0.315
2013 Latkin CA, German D, Vlahov D, Galea S. Neighborhoods and HIV: a social ecological approach to prevention and care. The American Psychologist. 68: 210-24. PMID 23688089 DOI: 10.1037/A0032704  0.401
2013 Cerdá M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, Vlahov D, Galea S. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug and Alcohol Dependence. 132: 53-62. PMID 23357743 DOI: 10.1016/J.Drugalcdep.2012.12.027  0.311
2013 Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, Hessol NA, Wilson TE, Plankey M, Howard AA, Sharp GB, Richardson JL, Cohen MH. Alcohol consumption trajectory patterns in adult women with HIV infection. Aids and Behavior. 17: 1705-12. PMID 22836592 DOI: 10.1007/S10461-012-0270-6  0.393
2012 Fu TC, Westergaard RP, Lau B, Celentano DD, Vlahov D, Mehta SH, Kirk GD. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users. Aids (London, England). 26: 2383-91. PMID 23079804 DOI: 10.1097/Qad.0B013E32835Ad438  0.427
2012 Manini AF, Nelson LS, Stimmel B, Vlahov D, Hoffman RS. Incidence of adverse cardiovascular events in adults following drug overdose. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 19: 843-9. PMID 22725631 DOI: 10.1111/J.1553-2712.2012.01397.X  0.361
2012 Ompad DC, Nandi V, Cerdá M, Crawford N, Galea S, Vlahov D. Beyond income: material resources among drug users in economically-disadvantaged New York City neighborhoods. Drug and Alcohol Dependence. 120: 127-34. PMID 21835561 DOI: 10.1016/J.Drugalcdep.2011.07.008  0.366
2012 Carrieri MP, Tamalet C, Vlahov D, Yahi N, Chesney M, Moatti JP. Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users. Addiction Biology. 4: 197-202. PMID 20575786 DOI: 10.1080/13556219971704  0.49
2011 Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, ... ... Vlahov D, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. Journal of the American Society of Nephrology : Jasn. 22: 2129-37. PMID 21997394 DOI: 10.1681/Asn.2011040388  0.357
2011 Factor SH, Sackoff JE, Raj-Singh S, Wu Y, Monserrate J, Munsiff S, Vlahov D. Street-outreach improves detection but not referral for drug users with latent tuberculosis, New York City. Substance Use & Misuse. 46: 1711-5. PMID 21943282 DOI: 10.3109/10826084.2011.615562  0.377
2011 Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA. Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduction Journal. 8: 22. PMID 21867518 DOI: 10.1186/1477-7517-8-22  0.481
2011 Friedland G, Vlahov D. Integration of buprenorphine for substance-abuse treatment by HIV care providers. Journal of Acquired Immune Deficiency Syndromes (1999). 56: S1-2. PMID 21317588 DOI: 10.1097/Qai.0B013E31820Bc9Ba  0.372
2011 Ompad DC, Friedman SR, Hwahng SJ, Nandi V, Fuller CM, Vlahov D. HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City. Substance Use & Misuse. 46: 274-84. PMID 21303247 DOI: 10.3109/10826084.2011.523284  0.39
2011 Vlahov D, Ompad DC, Fuller CM, Nandi V. Comparison of HIV risk by duration of injection drug use. Substance Use & Misuse. 46: 181-91. PMID 21303238 DOI: 10.3109/10826084.2011.521466  0.518
2011 Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Changes in blood-borne infection risk among injection drug users. The Journal of Infectious Diseases. 203: 587-94. PMID 21282191 DOI: 10.1093/Infdis/Jiq112  0.394
2011 Bohnert AS, Nandi A, Tracy M, Cerdá M, Tardiff KJ, Vlahov D, Galea S. Policing and risk of overdose mortality in urban neighborhoods. Drug and Alcohol Dependence. 113: 62-8. PMID 20727684 DOI: 10.1016/J.Drugalcdep.2010.07.008  0.358
2011 Frye V, Ompad D, Chan C, Koblin B, Galea S, Vlahov D. Intimate partner violence perpetration and condom use-related factors: associations with heterosexual men's consistent condom use. Aids and Behavior. 15: 153-62. PMID 20069447 DOI: 10.1007/S10461-009-9659-2  0.311
2010 Crawford ND, Vlahov D. Progress in HIV reduction and prevention among injection and noninjection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 55: S84-7. PMID 21406993 DOI: 10.1097/Qai.0B013E3181Fbca5A  0.501
2010 Freudenberg N, Ramaswamy M, Daniels J, Crum M, Ompad DC, Vlahov D. Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: evaluation of the REAL MEN re-entry program. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 47: 448-55. PMID 20970079 DOI: 10.1016/J.Jadohealth.2010.01.008  0.354
2010 Yanik EL, Lucas GM, Vlahov D, Kirk GD, Mehta SH. HIV and proteinuria in an injection drug user population. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1836-43. PMID 20705967 DOI: 10.2215/Cjn.01030210  0.491
2010 Manini AF, Kumar A, Olsen D, Vlahov D, Hoffman RS. Utility of serum lactate to predict drug-overdose fatality. Clinical Toxicology (Philadelphia, Pa.). 48: 730-6. PMID 20704455 DOI: 10.3109/15563650.2010.504187  0.301
2010 Panchanadeswaran S, Frye V, Nandi V, Galea S, Vlahov D, Ompad D. Intimate partner violence and consistent condom use among drug-using heterosexual women in New York City. Women & Health. 50: 107-24. PMID 20437300 DOI: 10.1080/03630241003705151  0.382
2010 Vlahov D, Robertson AM, Strathdee SA. Prevention of HIV infection among injection drug users in resource-limited settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: S114-21. PMID 20397939 DOI: 10.1086/651482  0.505
2010 Nandi A, Glass TA, Cole SR, Chu H, Galea S, Celentano DD, Kirk GD, Vlahov D, Latimer WW, Mehta SH. Neighborhood poverty and injection cessation in a sample of injection drug users. American Journal of Epidemiology. 171: 391-8. PMID 20093307 DOI: 10.1093/Aje/Kwp416  0.415
2010 Frye V, Koblin B, Chin J, Beard J, Blaney S, Halkitis P, Vlahov D, Galea S. Neighborhood-level correlates of consistent condom use among men who have sex with men: a multi-level analysis. Aids and Behavior. 14: 974-85. PMID 18712593 DOI: 10.1007/S10461-008-9438-5  0.309
2009 Ghebremichael M, Paintsil E, Ickovics JR, Vlahov D, Schuman P, Boland R, Schoenbaum E, Moore J, Zhang H. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. Aids Care. 21: 834-41. PMID 20024739 DOI: 10.1080/09540120802537864  0.356
2009 Castor D, Vlahov D, Hoover DR, Berkman A, Wu YF, Zeller B, Brechtl J, Hammer SM. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART. Journal of Medical Virology. 81: 1323-35. PMID 19551816 DOI: 10.1002/Jmv.21500  0.673
2009 Vlahov D, Strathdee S. The bottom line on cash incentives with drug users. Addiction (Abingdon, England). 104: 796-7. PMID 19413791 DOI: 10.1111/J.1360-0443.2009.02590.X  0.351
2009 Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein RS. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Preventive Medicine. 49: 68-73. PMID 19410600 DOI: 10.1016/J.Ypmed.2009.04.014  0.395
2009 Cook RL, Zhu F, Belnap BH, Weber K, Cook JA, Vlahov D, Wilson TE, Hessol NA, Plankey M, Howard AA, Cole SR, Sharp GB, Richardson JL, Cohen MH. Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. American Journal of Epidemiology. 169: 1025-32. PMID 19270052 DOI: 10.1093/Aje/Kwp004  0.364
2008 Golub JE, Astemborski J, Ahmed M, Cronin W, Mehta SH, Kirk GD, Vlahov D, Chaisson RE. Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 532-7. PMID 18989223 DOI: 10.1097/Qai.0B013E31818D5C1C  0.469
2008 Ompad DC, Fuller CM, Chan CA, Frye V, Vlahov D, Galea S. Correlates of illicit methadone use in New York City: a cross-sectional study. Bmc Public Health. 8: 375. PMID 18957116 DOI: 10.1186/1471-2458-8-375  0.416
2008 Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, Plankey MW, Levine AM, Levine A, Grey DD. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. Aids (London, England). 22: 1355-63. PMID 18580615 DOI: 10.1097/Qad.0B013E32830507F2  0.357
2008 Amon JJ, Garfein RS, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee SA, Hudson SM, Kerndt P, Des Jarlais D, Williams IT. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1852-8. PMID 18462109 DOI: 10.1086/588297  0.382
2008 Vlahov D, Wang C, Ompad D, Fuller CM, Caceres W, Ouellet L, Kerndt P, Jarlais DC, Garfein RS. Mortality risk among recent-onset injection drug users in five U.S. cities. Substance Use & Misuse. 43: 413-28. PMID 18365941 DOI: 10.1080/10826080701203013  0.383
2008 Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. The American Journal of Drug and Alcohol Abuse. 34: 161-70. PMID 18293232 DOI: 10.1080/00952990701877052  0.653
2008 Ompad DC, Galea S, Marshall G, Fuller CM, Weiss L, Beard JR, Chan C, Edwards V, Vlahov D. Sampling and recruitment in multilevel studies among marginalized urban populations: the IMPACT studies. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 85: 268-80. PMID 18214686 DOI: 10.1007/S11524-008-9256-0  0.34
2008 Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL. Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health. 33: 126-33. PMID 18165889 DOI: 10.1007/S10900-007-9083-3  0.341
2008 Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE. Erratum: Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 ositive women (AIDS (2008) 22:11 (1355-1363)) Aids. 22. DOI: 10.1097/01.Aids.0000335117.87221.1E  0.338
2007 Jones TS, Vlahov D. What we can learn from the INSPIRE Study about improving prevention and clinical care for injection drug users living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S31-4. PMID 18089982 DOI: 10.1097/Qai.0B013E318157892D  0.436
2007 Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. Aids (London, England). 21: 2435-43. PMID 18025880 DOI: 10.1097/Qad.0B013E32827038Ad  0.364
2007 Nash D, Andreopoulos E, Horowitz D, Sohler N, Vlahov D. Differences among U.S. states in estimating the number of people living with HIV/AIDS: impact on allocation of federal Ryan White funding. Public Health Reports (Washington, D.C. : 1974). 122: 644-56. PMID 17877312 DOI: 10.1177/003335490712200512  0.393
2007 Kirk GD, Vlahov D. Improving survival among HIV-infected injection drug users: how should we define success? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 377-80. PMID 17599318 DOI: 10.1086/519426  0.489
2007 Kirk GD, Merlo C, O' Driscoll P, Mehta SH, Galai N, Vlahov D, Samet J, Engels EA. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 103-10. PMID 17554710 DOI: 10.1086/518606  0.382
2007 Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 14: 616-23. PMID 17554010 DOI: 10.1197/J.Aem.2007.04.005  0.399
2007 Weiss L, Ompad D, Galea S, Vlahov D. Defining neighborhood boundaries for urban health research. American Journal of Preventive Medicine. 32: S154-9. PMID 17543706 DOI: 10.1016/J.Amepre.2007.02.034  0.339
2007 Vlahov D, O'Driscoll P, Mehta SH, Ompad DC, Gern R, Galai N, Kirk GD. Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. Addiction (Abingdon, England). 102: 771-7. PMID 17506154 DOI: 10.1111/J.1360-0443.2007.01767.X  0.47
2007 Mehta SH, Lucas G, Astemborski J, Kirk GD, Vlahov D, Galai N. Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users. Aids Care. 19: 637-45. PMID 17505924 DOI: 10.1080/09540120701235644  0.421
2007 Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G, Wu AW, Vlahov D. Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 298-303. PMID 17414930 DOI: 10.1097/Qai.0B013E318050D698  0.355
2007 Semba RD, Ricketts EP, Mehta SF, Kirk GD, Latkin C, Galai N, Vlahov D. Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore. The American Journal of Drug and Alcohol Abuse. 33: 71-80. PMID 17366247 DOI: 10.1080/00952990601082696  0.334
2007 Cook JA, Grey DD, Burke-Miller JK, Cohen MH, Vlahov D, Kapadia F, Wilson TE, Cook R, Schwartz RM, Golub ET, Anastos K, Ponath C, Goparaju L, Levine AM. Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence. 89: 74-81. PMID 17291696 DOI: 10.1016/J.Drugalcdep.2006.12.002  0.614
2007 Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health. 97: 117-24. PMID 17138929 DOI: 10.2105/Ajph.2005.069591  0.369
2007 Smit E, Crespo CJ, Semba RD, Jaworowicz D, Vlahov D, Ricketts EP, Ramirez-Marrero FA, Tang AM. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. Aids Care. 18: 1040-5. PMID 17012097 DOI: 10.1080/09540120600580926  0.46
2007 Galea S, Nandi A, Coffin PO, Tracy M, Markham Piper T, Ompad D, Vlahov D. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. Journal of Addictive Diseases. 25: 79-87. PMID 16956872 DOI: 10.1300/J069V25N03_10  0.374
2007 Cleland CM, Deren S, Fuller CM, Blaney S, McMahon JM, Tortu S, Des Jarlais DC, Vlahov D. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Education & Behavior : the Official Publication of the Society For Public Health Education. 34: 390-403. PMID 16816027 DOI: 10.1177/1090198106288560  0.361
2007 Messner SF, Galea S, Tardiff KJ, Tracy M, Bucciarelli A, Piper TM, Frye V, Vlahov D. Policing, drugs, and the homicide decline in New York City in the 1990s Criminology. 45: 385-414. DOI: 10.1111/J.1745-9125.2007.00082.X  0.304
2006 Carrieri MP, Amass L, Lucas GM, Vlahov D, Wodak A, Woody GE. Buprenorphine use: the international experience. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: S197-215. PMID 17109307 DOI: 10.1086/508184  0.484
2006 Shrestha S, Smith MW, Broman KW, Farzadegan H, Vlahov D, Strathdee SA. Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 335-43. PMID 16980914 DOI: 10.1097/01.Qai.0000230528.25083.0B  0.425
2006 Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, Nelson KE. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). Journal of Acquired Immune Deficiency Syndromes (1999). 43: 368-72. PMID 16980912 DOI: 10.1097/01.Qai.0000243050.27580.1A  0.51
2006 Ickovics JR, Milan S, Boland R, Schoenbaum E, Schuman P, Vlahov D. Psychological resources protect health: 5-year survival and immune function among HIV-infected women from four US cities. Aids (London, England). 20: 1851-60. PMID 16954726 DOI: 10.1097/01.Aids.0000244204.95758.15  0.397
2006 Pollini RA, McCall L, Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. American Journal of Preventive Medicine. 31: 261-4. PMID 16905039 DOI: 10.1016/J.Amepre.2006.04.002  0.386
2006 Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, et al. Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1 Journal of Virology. 80: 6757-6763. PMID 16809281 DOI: 10.1128/Jvi.00094-06  0.339
2006 Cofrancesco J, Shah N, Ghanem KG, Dobs AS, Klein RS, Mayer K, Schuman P, Vlahov D, Rompalo AM. The effects of illicit drug use and HIV infection on sex hormone levels in women. Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology. 22: 244-51. PMID 16785144 DOI: 10.1080/09513590600687603  0.439
2006 Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, Vlahov D, Dezzutti CS. Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 293-7. PMID 16763522 DOI: 10.1097/01.Qai.0000221689.77220.42  0.644
2006 Vlahov D, Putnam S. From corrections to communities as an HIV priority Journal of Urban Health. 83: 339-348. PMID 16739034 DOI: 10.1007/S11524-006-9041-X  0.346
2006 Wilson TE, Vlahov D, Crystal S, Absalon J, Klein SJ, Remien RH, Remein RH, Agins B. Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 83: 18-30. PMID 16736352 DOI: 10.1007/S11524-005-9004-7  0.436
2006 Absalon J, Fuller CM, Ompad DC, Blaney S, Koblin B, Galea S, Vlahov D. Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. Aids and Behavior. 10: 707-15. PMID 16676223 DOI: 10.1007/S10461-006-9082-X  0.451
2006 Deren S, Cleland CM, Fuller C, Kang SY, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. Aids and Behavior. 10: 717-21. PMID 16642418 DOI: 10.1007/S10461-006-9096-4  0.334
2006 Vlahov D, Celentano DD. Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death. Cadernos De SaúDe PúBlica. 22: 705-18. PMID 16612417 DOI: 10.1590/S0102-311X2006000400002  0.486
2006 Nandi A, Galea S, Ahern J, Bucciarelli A, Vlahov D, Tardiff K. What explains the association between neighborhood-level income inequality and the risk of fatal overdose in New York City? Social Science & Medicine (1982). 63: 662-74. PMID 16597478 DOI: 10.1016/J.Socscimed.2006.02.001  0.346
2006 Washington TA, Galai N, Cohn S, Celentano DD, Vlahov D, Strathdee SA. The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users. Archives of Sexual Behavior. 35: 67-74. PMID 16502154 DOI: 10.1007/S10508-006-8995-9  0.347
2006 Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. Aids Research and Human Retroviruses. 22: 14-21. PMID 16438640 DOI: 10.1089/Aid.2006.22.14  0.426
2006 Golub ET, Bareta JC, Mehta SH, McCall LD, Vlahov D, Strathdee SA. Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland. Substance Use & Misuse. 40: 1751-64. PMID 16419554 DOI: 10.1080/10826080500259513  0.434
2006 Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug and Alcohol Dependence. 83: 147-56. PMID 16364568 DOI: 10.1016/J.Drugalcdep.2005.11.007  0.47
2006 Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O'Brien SJ, Smith MW. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. The Journal of Infectious Diseases. 193: 16-26. PMID 16323127 DOI: 10.1086/498532  0.372
2006 Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug and Alcohol Dependence. 83: 104-10. PMID 16310322 DOI: 10.1016/J.Drugalcdep.2005.10.015  0.379
2006 Deloria-Knoll M, Steinhoff M, Semba RD, Nelson K, Vlahov D, Meinert CL. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine. 24: 1670-9. PMID 16256250 DOI: 10.1016/J.Vaccine.2005.09.047  0.374
2006 Galea S, Messner S, Markham PT, Bucciarelli A, Frye V, Tardiff K, Vlahov D. Policing, Drugs, and Declining Homicide Levels in New York City in the 1990's American Journal of Epidemiology. 163: S159-S159. DOI: 10.1093/Aje/163.Suppl_11.S159-B  0.328
2006 Wilson TE, Vlahov D, Crystal S, Absalon J, Klein SJ, Remien RH, Agins B. Integrating HIV Prevention Activities into the HIV Medical Care Setting: A Report from the NYC HIV Centers Consortium Journal of Urban Health. 84: 460-460. DOI: 10.1007/S11524-006-9117-7  0.4
2005 Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. Journal of Psychoactive Drugs. 37: 437-43. PMID 16480171 DOI: 10.1080/02791072.2005.10399817  0.397
2005 Latka MH, Wilson TE, Cook JA, Bacon MC, Richardson JL, Sohler N, Cohen MH, Greenblatt RM, Andreopoulis E, Vlahov D. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study. Journal of Substance Abuse Treatment. 29: 329-37. PMID 16311186 DOI: 10.1016/J.Jsat.2005.08.008  0.394
2005 Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nature Medicine. 11: 1290-2. PMID 16288280 DOI: 10.1038/Nm1333  0.342
2005 Bryant WK, Ompad DC, Ahern J, Wu Y, Vlahov D, Galea S. Period and birth-cohort effects on age of first phencyclidine (PCP) use among drug users in New York City, 1960 to 2000. Annals of Epidemiology. 16: 266-72. PMID 16275133 DOI: 10.1016/J.Annepidem.2005.07.059  0.378
2005 Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users Aids. 19. PMID 16251816 DOI: 10.1097/01.Aids.0000192088.72055.90  0.396
2005 Dancheck B, Tang AM, Thomas AM, Smit E, Vlahov D, Semba RD. Injection drug use is an independent risk factor for iron deficiency and iron deficiency anemia among HIV-seropositive and HIV-seronegative women. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 198-201. PMID 16186738 DOI: 10.1097/01.Qai.0000165909.12333.07  0.415
2005 Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study Genes and Immunity. 6: 691-698. PMID 16177829 DOI: 10.1038/Sj.Gene.6364258  0.341
2005 Novoa RA, Ompad DC, Wu Y, Vlahov D, Galea S. Ecstasy use and its association with sexual behaviors among drug users in New York City Journal of Community Health. 30: 331-343. PMID 16175956 DOI: 10.1007/S10900-005-5515-0  0.394
2005 Milan S, Ickovics J, Boland R, Schoenbaum E, Schuman P, Vlahov D, Moore J. Interpersonal predictors of depression trajectories in women with HIV Journal of Consulting and Clinical Psychology. 73: 678-688. PMID 16173855 DOI: 10.1037/0022-006X.73.4.678  0.371
2005 Kapadia F, Vlahov D, Donahoe RM, Friedland G. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1027-34. PMID 16142670 DOI: 10.1086/433175  0.644
2005 Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. Community incidence of hepatitis B and C among reincarcerated women Clinical Infectious Diseases. 41: 998-1002. PMID 16142665 DOI: 10.1086/432936  0.357
2005 Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee SA. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. Aids and Behavior. 9: 289-99. PMID 16133905 DOI: 10.1007/S10461-005-9003-4  0.469
2005 Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug and Alcohol Dependence. 79: 389-95. PMID 16102381 DOI: 10.1016/J.Drugalcdep.2005.03.004  0.353
2005 Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, Strathdee SA. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. Aids and Behavior. 9: 301-9. PMID 16088366 DOI: 10.1007/S10461-005-9004-3  0.451
2005 Galea S, Rudenstine S, Vlahov D. Drug use, misuse, and the urban environment Drug and Alcohol Review. 24: 127-136. PMID 16076582 DOI: 10.1080/09595230500102509  0.342
2005 Ompad DC, Galea S, Fuller CM, Edwards V, Vlahov D. Ecstasy use among Hispanic and black substance users in New York City. Substance Use & Misuse. 40: 1399-407. PMID 16048824 DOI: 10.1081/Ja-200066960  0.389
2005 Pouget ER, Deren S, Fuller CM, Blaney S, McMahon JM, Kang SY, Tortu S, Andia JF, Des Jarlais DC, Vlahov D. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 471-7. PMID 16010172 DOI: 10.1097/01.Qai.0000152395.82885.C0  0.367
2005 Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, Galea S. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug and Alcohol Dependence. 79: 181-90. PMID 16002027 DOI: 10.1016/J.Drugalcdep.2005.01.010  0.394
2005 Kapadia F, Cook JA, Cohen MH, Sohler N, Kovacs A, Greenblatt RM, Choudhary I, Vlahov D. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (Abingdon, England). 100: 990-1002. PMID 15955015 DOI: 10.1111/J.1360-0443.2005.01098.X  0.652
2005 Wang C, Vlahov D, Galai N, Cole SR, Bareta J, Pollini R, Mehta SH, Nelson KE, Galea S. The effect of HIV infection on overdose mortality. Aids (London, England). 19: 935-42. PMID 15905674 DOI: 10.1097/01.Aids.0000171407.30866.22  0.404
2005 Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. American Journal of Epidemiology. 161: 999-1012. PMID 15901620 DOI: 10.1093/Aje/Kwi133  0.43
2005 Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 951-8. PMID 15824985 DOI: 10.1086/428578  0.301
2005 Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D, Garfein R, Strathdee SA. Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health. 95: 703-9. PMID 15798133 DOI: 10.2105/Ajph.2003.019372  0.356
2005 Fuller CM, Borrell LN, Latkin CA, Galea S, Ompad DC, Strathdee SA, Vlahov D. Effects of race, neighborhood, and social network on age at initiation of injection drug use. American Journal of Public Health. 95: 689-95. PMID 15798131 DOI: 10.2105/Ajph.2003.02178  0.392
2005 Lai S, Lima JA, Lai H, Vlahov D, Celentano D, Tong W, Bartlett JG, Margolick J, Fishman EK. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Archives of Internal Medicine. 165: 690-5. PMID 15795348 DOI: 10.1001/Archinte.165.6.690  0.379
2005 Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D. The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 584-9. PMID 15793370 DOI: 10.1097/01.Qai.0000134741.49208.03  0.408
2005 Lambert E, Normand J, Stall R, Aral S, Vlahov D. Introduction: New dynamics of HIV risk among drug-using men who have sex with men Journal of Urban Health. 82. PMID 15738326 DOI: 10.1093/Jurban/Jti018  0.421
2005 Fuller CM, Absalon J, Ompad DC, Nash D, Koblin B, Blaney S, Galea S, Vlahov D. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 82: i51-61. PMID 15738320 DOI: 10.1093/Jurban/Jti024  0.487
2005 Sterling TR, Pisell-Noland T, Perez JL, Astemborski J, McGriff JR, Nutting L, Hoover DR, Vlahov D, Bollinger RC. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. The Journal of Infectious Diseases. 191: 881-5. PMID 15717262 DOI: 10.1086/427827  0.324
2005 Smit E, Semba RD, Pilibosian E, Vlahov D, Tun W, Purvis L, Tang AM. Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. Aids Patient Care and Stds. 19: 19-30. PMID 15665632 DOI: 10.1089/Apc.2005.19.19  0.454
2005 Hembree C, Galea S, Ahern J, Tracy M, Markham Piper T, Miller J, Vlahov D, Tardiff KJ. The urban built environment and overdose mortality in New York City neighborhoods. Health & Place. 11: 147-56. PMID 15629682 DOI: 10.1016/J.Healthplace.2004.02.005  0.372
2005 Galai N, Vlahov D, Bareta JC, Wang C, Cohn S, Sterling TR. Prognostic factors for survival differ according to CD4+ cell count among HIV-infected injection drug users: pre-HAART and HAART eras. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 74-81. PMID 15608529 DOI: 10.1097/00126334-200501010-00014  0.423
2005 Dorrucci M, Valdarchi C, Suligoi B, Zaccarelli M, Sinicco A, Giuliani M, Vlahov D, Pezzotti P, Rezza G. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy. Aids (London, England). 18: 2313-8. PMID 15577544 DOI: 10.1097/00002030-200411190-00012  0.353
2005 Hamburger ME, Moore J, Koenig LJ, Vlahov D, Schoenbaum EE, Schuman P, Mayer K. Persistence of inconsistent condom use: relation to abuse history and HIV serostatus. Aids and Behavior. 8: 333-44. PMID 15475680 DOI: 10.1023/B:AIBE.0000044080.04397.97  0.323
2005 Tardiff AKJ, Wallace Z, Tracy M, Piper TM, Vlahov D, Galea S. Drug and Alcohol Use as Determinants of New York City Homicide Trends From 1990 to 1998 Journal of Forensic Sciences. 50: 1-5. DOI: 10.1520/Jfs2004287  0.314
2005 Smit E, Crespo CJ, Semba RD, Jaworowicz D, Vlahov D, Tang AM. Physical Activity In A Cohort Of HIV-positive And HIV-negative Injection Drug Users Medicine & Science in Sports & Exercise. 37: S322. DOI: 10.1097/00005768-200505001-01666  0.469
2005 OMPAD D, BLANEY S, SISCO S, GLIDDEN K, VLAHOV D, GALEA S. Enumeration of hard-to-reach populations for a community-based vaccine distribution study Annals of Epidemiology. 15: 651-651. DOI: 10.1016/J.Annepidem.2005.07.015  0.303
2004 Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'brien SJ, Phair J, Vlahov D, Jacobson LP, Rappaport J, Vasilescu A, Bertin-Maghit S, An P, Lu W, Andrieu JM, et al. Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression. Journal of Acquired Immune Deficiency Syndromes (1999). 37: 1534-8. PMID 15602133 DOI: 10.1097/01.Qai.0000127353.01578.63  0.344
2004 Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. Journal of Virology. 78: 14053-6. PMID 15564514 DOI: 10.1128/Jvi.78.24.14053-14056.2004  0.375
2004 Ompad DC, Galea S, Fuller CM, Phelan D, Vlahov D. Club drug use among minority substance users in New York City. Journal of Psychoactive Drugs. 36: 397-9. PMID 15559686 DOI: 10.1080/02791072.2004.10400039  0.386
2004 Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 31: 210-4. PMID 15465414 DOI: 10.1016/J.Jcv.2004.03.014  0.381
2004 An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, et al. APOBEC3G genetic variants and their influence on the progression to AIDS. Journal of Virology. 78: 11070-6. PMID 15452227 DOI: 10.1128/Jvi.78.20.11070-11076.2004  0.393
2004 Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. The Journal of Infectious Diseases. 190: 1046-54. PMID 15319852 DOI: 10.1086/422848  0.312
2004 Becker Buxton M, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein RS. Association between injection practices and duration of injection among recently initiated injection drug users. Drug and Alcohol Dependence. 75: 177-83. PMID 15276223 DOI: 10.1016/J.Drugalcdep.2004.01.014  0.391
2004 Vlahov D, Wang CL, Galai N, Bareta J, Mehta SH, Strathdee SA, Nelson KE. Mortality risk among new onset injection drug users. Addiction (Abingdon, England). 99: 946-54. PMID 15265091 DOI: 10.1111/J.1360-0443.2004.00780.X  0.342
2004 Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiologic Reviews. 26: 36-52. PMID 15234946 DOI: 10.1093/Epirev/Mxh007  0.314
2004 Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health. 94: 1218-23. PMID 15226146 DOI: 10.2105/Ajph.94.7.1218  0.414
2004 Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, Kerndt PR, Word C, Fernando MD, Ouellet LJ, Holmberg SD. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 81: 260-7. PMID 15136659 DOI: 10.1093/Jurban/Jth112  0.482
2004 Rompalo AM, Shah N, Margolick JB, Farzadegan H, Arnsten J, Schuman P, Rich JD, Gardner LI, Smith DK, Vlahov D. Evaluation of possible effects of continued drug use on HIV progression among women. International Journal of Std & Aids. 15: 322-7. PMID 15117502 DOI: 10.1177/095646240401500510  0.497
2004 Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 1167-74. PMID 15095224 DOI: 10.1086/383033  0.482
2004 Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, Yu XF. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology. 33: 182-8. PMID 15075167 DOI: 10.1093/Ije/Dyh019  0.339
2004 Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 81: 20-4. PMID 15047780 DOI: 10.1093/Jurban/Jth084  0.337
2004 Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 81: 14-9. PMID 15047779 DOI: 10.1093/Jurban/Jth083  0.419
2004 Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 35: 503-10. PMID 15021315 DOI: 10.1097/00126334-200404150-00008  0.494
2004 Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology (Baltimore, Md.). 39: 51-7. PMID 14752822 DOI: 10.1002/Hep.20025  0.307
2004 Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 438-41. PMID 14727219 DOI: 10.1086/381095  0.401
2004 Kapadia F, Vlahov D, DesJerlais DC. Erratum: Does bleach disinfection of syringes protect against Hepatitis C infection among young adult injection drug users? (Epidemiology (2002) 13 (738-741)) Epidemiology. 15. DOI: 10.1097/01.Ede.0000121546.94885.23  0.598
2003 Galea S, Ahern J, Vlahov D. Contextual Determinants of Drug Use Risk Behavior: A Theoretic Framework Journal of Urban Health. 80. PMID 14713671 DOI: 10.1093/Jurban/Jtg082  0.387
2003 Normand JL, Lambert EY, Vlahov D. Understanding the Dynamics of Sexual Transmission of HIV among Drug-Using Populations: An Integration of Biological, Behavioral, and Environmental Perspectives Journal of Urban Health. 80. PMID 14713666 DOI: 10.1093/Jurban/Jtg077  0.488
2003 Royal W, Vlahov D, Lyles C, Gajewski CD. Retinoids and Drugs of Abuse: Implications for Neurological Disease Risk in Human Immunodeficiency Virus Type 1 Infection Clinical Infectious Diseases. 37. PMID 14648459 DOI: 10.1086/377554  0.497
2003 Zwahlen M, Vlahov D. Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users International Journal of Epidemiology. 32: 715-716. PMID 14559737 DOI: 10.1093/Ije/Dyg169  0.483
2003 Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: Description and determinants American Journal of Epidemiology. 158: 695-704. PMID 14507606 DOI: 10.1093/Aje/Kwg209  0.419
2003 Tun W, Celentano DD, Vlahov D, Strathdee SA. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. Aids (London, England). 17: 1953-62. PMID 12960828 DOI: 10.1097/00002030-200309050-00014  0.465
2003 Mayer KH, Hogan JW, Smith D, Klein RS, Schuman P, Margolick JB, Korkontzelou C, Farzedegan H, Vlahov D, Carpenter CC. Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 614-24. PMID 12902807 DOI: 10.1097/00126334-200308150-00011  0.393
2003 Pilowsky DJ, Zybert PA, Hsieh PW, Vlahov D, Susser E. Children of HIV-positive drug-using parents. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 950-6. PMID 12874497 DOI: 10.1097/01.Chi.0000046888.27264.17  0.451
2003 Lai S, Lai H, Celentano DD, Vlahov D, Ren S, Margolick J, Lima JA, Bartlett JG. Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. Aids Patient Care and Stds. 17: 211-9. PMID 12816615 DOI: 10.1089/108729103321655863  0.359
2003 Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction (Abingdon, England). 98: 739-47. PMID 12780362 DOI: 10.1046/J.1360-0443.2003.00376.X  0.376
2003 Koblin BA, Factor SH, Wu Y, Vlahov D. Hepatitis C virus infection among noninjecting drug users in New York City Journal of Medical Virology. 70: 387-390. PMID 12767001 DOI: 10.1002/Jmv.10407  0.397
2003 Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes and Immunity. 4: 245-50. PMID 12761559 DOI: 10.1038/Sj.Gene.6363950  0.329
2003 Galea S, Ahern J, Vlahov D, Coffin PO, Fuller C, Leon AC, Tardiff K. Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug and Alcohol Dependence. 70: 139-48. PMID 12732407 DOI: 10.1016/S0376-8716(02)00342-3  0.36
2003 Stover CT, Smith DK, Schmid DS, Pellett PE, Stewart JA, Klein RS, Mayer K, Vlahov D, Schuman P, Cannon MJ. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. The Journal of Infectious Diseases. 187: 1388-96. PMID 12717619 DOI: 10.1086/374649  0.436
2003 Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 55: 157-64. PMID 12715242 DOI: 10.1007/S00251-003-0541-5  0.389
2003 Juday TR, Wu A, Celentano DD, Frick KD, Wang MC, Vlahov D. The role of Medicaid HMO enrollment in the longitudinal utilization of medical care services in a cohort of injecting drug users in Baltimore, Maryland. Substance Abuse. 24: 27-41. PMID 12652093 DOI: 10.1080/08897070309511531  0.405
2003 Kuo I, Brady J, Butler C, Schwartz R, Brooner R, Vlahov D, Strathdee SA. Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. Journal of Substance Abuse Treatment. 24: 67-74. PMID 12646332 DOI: 10.1016/S0740-5472(02)00343-4  0.328
2003 Golub ET, Astemborski JA, Hoover DR, Anthony JC, Vlahov D, Strathdee SA. Psychological distress and progression to AIDS in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 32: 429-34. PMID 12640202 DOI: 10.1097/00126334-200304010-00013  0.695
2003 Bernstein KT, Jacobson LP, Jenkins FJ, Vlahov D, Armenian HK. Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort. Sexually Transmitted Diseases. 30: 199-204. PMID 12616135 DOI: 10.1097/00007435-200303000-00004  0.408
2003 Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology. 157: 467-71. PMID 12615611 DOI: 10.1093/Aje/Kwf222  0.404
2003 Henderson LA, Vlahov D, Celentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program Journal of Acquired Immune Deficiency Syndromes. 32: 229-237. PMID 12571535 DOI: 10.1097/00126334-200302010-00017  0.416
2003 Sheu M, Hogan J, Allsworth J, Stein M, Vlahov D, Schoenbaum EE, Schuman P, Gardner L, Flanigan T. Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. Journal of Women's Health (2002). 11: 743-50. PMID 12570040 DOI: 10.1089/15409990260363698  0.413
2003 Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 32: 86-93. PMID 12514419 DOI: 10.1097/00126334-200301010-00013  0.469
2003 Kapadia F, Garfein RS, Vlahov D. Does Bleach Disinfection of Syringes Help Prevent Hepatitis C Virus Transmission? Epidemiology. 14: 629. DOI: 10.1097/01.Ede.0000081991.99869.A0  0.519
2003 Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, et al. Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression Aids. 17: 377-387. DOI: 10.1097/00002030-200302140-00012  0.422
2003 Deren S, Fuller C, Pouget ER, Blaney S, Tortu S, Kang SY, McMahon JM, Andia JF, Des Jarlais DC, Johnson B, Rosenblum A, Vlahov D. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA International Journal of Drug Policy. 14: 373-379. DOI: 10.1016/S0955-3959(03)00137-3  0.375
2002 Riley ED, Safaeian M, Strathdee SA, Brooner RK, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Substance Use & Misuse. 37: 1869-86. PMID 12511056 DOI: 10.1081/Ja-120014088  0.306
2002 Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 42: S77-82. PMID 12489621 DOI: 10.1331/1086-5802.42.0.S77.Fuller  0.396
2002 Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 42: S62-7. PMID 12489618 DOI: 10.1331/1086-5802.42.0.S62.Coffin  0.377
2002 Gruskin L, Gange SJ, Celentano D, Schuman P, Moore JS, Zierler S, Vlahov D. Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 79: 512-24. PMID 12468671 DOI: 10.1093/Jurban/79.4.512  0.42
2002 Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users Aids Education and Prevention. 14: 367-378. PMID 12413183 DOI: 10.1521/Aeap.14.6.367.24075  0.47
2002 Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, Morse E EV, Williams I, Garfein RS. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (Cambridge, Mass.). 13: 738-41. PMID 12410020 DOI: 10.1097/00001648-200211000-00023  0.598
2002 Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. Aids (London, England). 16: 2175-82. PMID 12409739 DOI: 10.1097/00002030-200211080-00010  0.396
2002 Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee SA, Nelson KE, Wu KC, Chen S, Tong W, Lai S. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. American Heart Journal. 144: 642-8. PMID 12360160 DOI: 10.1067/Mhj.2002.125009  0.348
2002 Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. The Journal of Infectious Diseases. 186: 1181-5. PMID 12355373 DOI: 10.1086/343807  0.367
2002 Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. American Journal of Epidemiology. 156: 641-53. PMID 12244033 DOI: 10.1093/Aje/Kwf086  0.493
2002 Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 35: 783-8. PMID 12228813 DOI: 10.1086/342063  0.351
2002 Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program American Journal of Drug and Alcohol Abuse. 28: 497-511. PMID 12211362 DOI: 10.1081/Ada-120006738  0.344
2002 Factor SH, Wu Y, Monserrate J, Edwards V, Cuevas Y, Del Vecchio S, Vlahov D. Drug use frequency among street-recruited heroin and cocaine users in Harlem and the Bronx before and after September 11, 2001. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 79: 404-8. PMID 12200509 DOI: 10.1093/Jurban/79.3.404  0.329
2002 Downer MV, Hodge T, Smith DK, Qari SH, Schuman P, Mayer KH, Klein RS, Vlahov D, Gardner LI, McNicholl JM. Regional variation in CCR5-Delta32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes and Immunity. 3: 295-8. PMID 12140749 DOI: 10.1038/Sj.Gene.6363884  0.353
2002 Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee S, Nelson KE, Tong W, Lai S. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. Journal of Acquired Immune Deficiency Syndromes (1999). 30: 306-10. PMID 12131567 DOI: 10.1097/00126334-200207010-00006  0.362
2002 An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J, Vlahov D, Buchbinder S, Farrar WL, Modi W, O'Brien SJ, Winkler CA. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy of Sciences of the United States of America. 99: 10002-7. PMID 12114533 DOI: 10.1073/Pnas.142313799  0.366
2002 Wilson LE, Thomas DL, Astemborski J, Freedman TL, Vlahov D. Prospective study of infective endocarditis among injection drug users. The Journal of Infectious Diseases. 185: 1761-6. PMID 12085322 DOI: 10.1086/340827  0.522
2002 Factor SH, Galea S, de Duenas Geli LG, Saynisch M, Blumenthal S, Canales E, Poulson M, Foley M, Vlahov D. Development of a "survival" guide for substance users in Harlem, New York City. Health Education & Behavior : the Official Publication of the Society For Public Health Education. 29: 312-25. PMID 12038741 DOI: 10.1177/109019810202900304  0.305
2002 Celentano DD, Cohn S, Davis RO, Vlahov D. Self-efficacy estimates for drug use practices predict risk reduction among injection drug users Journal of Urban Health. 79: 245-256. PMID 12023500 DOI: 10.1093/Jurban/79.2.245  0.437
2002 Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology (Baltimore, Md.). 35: 1247-55. PMID 11981775 DOI: 10.1053/Jhep.2002.33151  0.376
2002 Bouhnik AD, Moatti JP, Vlahov D, Gallais H, Dellamonica P, Obadia Y. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. Journal of Epidemiology and Community Health. 56: 349-53. PMID 11964431 DOI: 10.1136/Jech.56.5.349  0.482
2002 Galea S, Ahern J, Tardiff K, Leon AC, Vlahov D. Drugs and firearm deaths in New York City, 1990-1998. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 79: 70-86. PMID 11937617 DOI: 10.1093/Jurban/79.1.70  0.323
2002 Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug and Alcohol Dependence. 66: 189-98. PMID 11906806 DOI: 10.1016/S0376-8716(01)00200-9  0.444
2002 Semba RD, Shah N, Vlahov D. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. International Journal of Std & Aids. 13: 119-23. PMID 11839167 DOI: 10.1258/0956462021924758  0.361
2002 Semba RD, Shah N, Strathdee SA, Vlahov D. High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 29: 142-4. PMID 11832682 DOI: 10.1097/00042560-200202010-00005  0.459
2002 Safaeian M, Brookmeyer R, Vlahov D, Latkin C, Marx M, Strathdee SA. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. American Journal of Epidemiology. 155: 169-75. PMID 11790681 DOI: 10.1093/Aje/155.2.169  0.432
2002 Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 260-6. PMID 11740716 DOI: 10.1086/338151  0.391
2002 Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. Journal of Substance Abuse. 13: 17-27. PMID 11547618 DOI: 10.1016/S0899-3289(01)00073-6  0.35
2002 Vertefeuille J, Strathdee SA, Huettner S, Brown M, Vlahov D. Factors Associated with HIV Seroprevalence among Participants Enrolling at a Needle Exchange Program Journal of Drug Issues. 32: 1125-1138. DOI: 10.1177/002204260203200408  0.481
2002 Arria AM, Fuller C, Strathdee SA, Latkin C, Vlahov D. Drug Dependence among Young Recently Initiated Injection Drug Users Journal of Drug Issues. 32: 1089-1102. DOI: 10.1177/002204260203200405  0.37
2002 Diaz T, Vlahov D, Edwards V, Conover S, Monterroso E. Aids and Behavior. 6: 117-122. DOI: 10.1023/A:1015441030030  0.467
2002 Galea S, Tardiff K, Ahern J, Leon A, Vlahov D. #44 Changing racial/ethnic disparities in homicide mortality in nyc 1990–98 Annals of Epidemiology. 12: 505-506. DOI: 10.1016/S1047-2797(02)00332-0  0.314
2001 Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use Public Health Reports. 116: 136-145. PMID 11889281 DOI: 10.1093/Phr/116.S1.136  0.381
2001 Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, Jamieson DJ, Vlahov D, Schuman P, Holmberg SD. Cancer incidence in women with or at risk for HIV. International Journal of Cancer. Journal International Du Cancer. 94: 753-7. PMID 11745473 DOI: 10.1002/Ijc.1528  0.407
2001 Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD, Strathdee SA. Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy American Journal of Epidemiology. 154: S70-S77. PMID 11744532 DOI: 10.1093/Aje/154.12.S70  0.372
2001 Vlahov D, Safaien M, Lai S, Strathdee SA, Johnson L, Sterling T, Celentano DD. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users Aids. 15: 2311-2316. PMID 11698705 DOI: 10.1097/00002030-200111230-00013  0.433
2001 Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, ... ... Vlahov D, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Annals of Internal Medicine. 135: 782-95. PMID 11694103 DOI: 10.7326/0003-4819-135-9-200111060-00008  0.392
2001 Wilson LE, Umemura T, Astemborski J, Ray SC, Alter HJ, Strathdee SA, Vlahov D, Thomas DL. Dynamics of SEN virus infection among injection drug users. The Journal of Infectious Diseases. 184: 1315-9. PMID 11679921 DOI: 10.1086/324001  0.315
2001 Sadaphal P, Astemborski J, Graham NM, Sheely L, Bonds M, Madison A, Vlahov D, Thomas DL, Sterling TR. Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 33: 1687-91. PMID 11641824 DOI: 10.1086/323896  0.433
2001 Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Gardner LI, Vlahov D. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. Aids Patient Care and Stds. 15: 473-80. PMID 11587633 DOI: 10.1089/108729101753145466  0.344
2001 Rompalo AM, Shah N, Mayer K, Schuman P, Klein RS, Smith DK, Vlahov D. Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV Epidemiology Research study: on-site versus referral care. Journal of Acquired Immune Deficiency Syndromes (1999). 28: 28-34. PMID 11579274 DOI: 10.1097/00042560-200109010-00005  0.473
2001 Latka M, Ahern J, Garfein RS, Ouellet L, Kerndt P, Morse P, Farshy CE, Des Jarlais DC, Vlahov D. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users Journal of Substance Abuse. 13: 73-88. PMID 11547626 DOI: 10.1016/S0899-3289(01)00071-2  0.332
2001 Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, Gallant JE. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. Aids (London, England). 15: 1707-15. PMID 11546947 DOI: 10.1097/00002030-200109070-00015  0.486
2001 Knowlton AR, Hoover DR, Chung SE, Celentano DD, Vlahov D, Latkin CA. Access to medical care and service utilization among injection drug users with HIV/AIDS Drug and Alcohol Dependence. 64: 55-62. PMID 11470341 DOI: 10.1016/S0376-8716(00)00228-3  0.375
2001 Diaz T, Vlahov D, Greenberg B, Cuevas Y, Garfein R. Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. Journal of Women's Health & Gender-Based Medicine. 10: 371-80. PMID 11445028 DOI: 10.1089/152460901750269698  0.452
2001 Riley ED, Chaisson RE, Robnett TJ, Vertefeuille J, Strathdee SA, Vlahov D. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors American Journal of Respiratory and Critical Care Medicine. 164: 82-85. PMID 11435243 DOI: 10.1164/Ajrccm.164.1.2101091  0.399
2001 Valente T, Foreman R, Junge B, Vlahov D. Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health Journal of Urban Health. 78: 340-349. PMID 11419584 DOI: 10.1093/Jurban/78.2.340  0.468
2001 Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow RA, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, O'Brien SJ, Carrington M. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. The New England Journal of Medicine. 344: 1668-1675. PMID 11386265 DOI: 10.1056/Nejm200105313442203  0.329
2001 Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective Archives of Internal Medicine. 161: 1281-1288. PMID 11371255 DOI: 10.1001/Archinte.161.10.1281  0.481
2001 Semba RD, Shah N, Vlahov D. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes. 26: 315-319. PMID 11317071 DOI: 10.1097/00126334-200104010-00003  0.427
2001 Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. European Addiction Research. 7: 40-5. PMID 11316925 DOI: 10.1159/000050713  0.415
2001 Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study Journal of the American Medical Association. 285: 1466-1474. PMID 11255423 DOI: 10.1001/Jama.285.11.1466  0.361
2001 Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies Journal of Virology. 75: 3259-3267. PMID 11238852 DOI: 10.1128/Jvi.75.7.3259-3267.2001  0.396
2001 Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men New England Journal of Medicine. 344: 720-725. PMID 11236775 DOI: 10.1056/Nejm200103083441003  0.386
2001 Valente TW, Vlahov D. Selective risk taking among needle exchange participants: Implications for supplemental interventions American Journal of Public Health. 91: 406-411. PMID 11236405 DOI: 10.2105/Ajph.91.3.406  0.434
2001 Diaz T, Des Jarlais DC, Vlahov D, Perlis TE, Edwards V, Friedman SR, Rockwell R, Hoover D, Williams IT, Monterroso ER. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health. 91: 23-30. PMID 11189819 DOI: 10.2105/Ajph.91.1.23  0.382
2001 Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP. Injecting misuse of buprenorphine among French drug users. Addiction (Abingdon, England). 96: 267-72. PMID 11182872 DOI: 10.1046/J.1360-0443.2001.96226710.X  0.411
2001 Celentano DD, Muñoz A, Cohn S, Vlahov D. Dynamics of behavioral risk factors for HIV/AIDS: A 6-year prospective study of injection drug users Drug and Alcohol Dependence. 61: 315-322. PMID 11164696 DOI: 10.1016/S0376-8716(00)00154-X  0.45
2001 Pilowsky DJ, Lyles CM, Cross SI, Celentano D, Nelson KE, Vlahov D. Characteristics of injection drug using parents who retain their children. Drug and Alcohol Dependence. 61: 113-22. PMID 11137275 DOI: 10.1016/S0376-8716(00)00130-7  0.384
2001 Shrestha S, Strathdee SA, Brahmbhatt H, Farzadegan H, Vlahov D, Smith MW. Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes. Aids (London, England). 14: 1507-13. PMID 10983637 DOI: 10.1097/00002030-200007280-00006  0.348
2000 Coffin PO, Linas BP, Factor SH, Vlahov D. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access Journal of Urban Health. 77: 781-793. PMID 11194317 DOI: 10.1007/Bf02344038  0.454
2000 Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation Journal of Urban Health. 77: 768-780. PMID 11194316 DOI: 10.1007/Bf02344037  0.39
2000 Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection Journal of Urban Health. 77: 678-687. PMID 11194310 DOI: 10.1007/Bf02344031  0.5
2000 Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proceedings of the National Academy of Sciences of the United States of America. 97: 14467-72. PMID 11121048 DOI: 10.1073/Pnas.97.26.14467  0.305
2000 An P, Martin MP, Nelson GW, Carrington M, Smith MW, Gong K, Vlahov D, O'Brien SJ, Winkler CA. Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. Aids (London, England). 14: 2117-22. PMID 11061652 DOI: 10.1097/00002030-200009290-00007  0.342
2000 Safaeian M, Wilson LE, Taylor E, Thomas DL, Vlahov D. HTLV-II and bacterial infections among injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 24: 483-7. PMID 11035620 DOI: 10.1097/00126334-200008150-00014  0.384
2000 Shah NG, Celentano DD, Vlahov D, Stambolis V, Johnson L, Nelson KE, Strathdee SA. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus Aids. 14: 2035-2043. PMID 10997409 DOI: 10.1097/00002030-200009080-00020  0.457
2000 Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults Journal of Urban Health. 77: 396-414. PMID 10976613 DOI: 10.1007/Bf02386749  0.428
2000 Ahdieh L, Muñoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. American Journal of Epidemiology. 151: 1148-57. PMID 10905527 DOI: 10.1093/Oxfordjournals.Aje.A010165  0.382
2000 Riley ED, Safaeian M, Strathdee SA, Marx MA, Huettner S, Beilenson P, Vlahov D. Comparing new participants of a mobile versus a pharmacy-based needle exchange program Journal of Acquired Immune Deficiency Syndromes. 24: 57-61. PMID 10877496 DOI: 10.1097/00126334-200005010-00010  0.327
2000 Greenberg B, McCorkle R, Vlahov D, Selwyn PA. Palliative care for HIV disease in the era of highly active antiretroviral therapy Journal of Urban Health. 77: 150-165. PMID 10855997 DOI: 10.1007/Bf02390527  0.345
2000 Zwahlen M, Neuenschwander BE, Jeannin A, Dubois-Arber F, Vlahov D. HIV testing and retesting for men and women in Switzerland. European Journal of Epidemiology. 16: 123-33. PMID 10845261 DOI: 10.1023/A:1007638823567  0.375
2000 Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users Aids. 14: 717-726. PMID 10807195 DOI: 10.1097/00002030-200004140-00011  0.517
2000 Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. Determinants of the quantity of hepatitis C virus RNA Journal of Infectious Diseases. 181: 844-851. PMID 10720503 DOI: 10.1086/315314  0.307
2000 Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macalino G, Nelson K, Vlahov D. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 76: 448-60. PMID 10609594 DOI: 10.1007/Bf02351502  0.508
2000 Vlahov D, Tang AM, Lyles C, Rezza G, Thomas D, Cohn S, Macalino G, Stambolis V, Nelson KE. Increased Frequency of Overdose Deaths Among HIV-Infected Injection Drug Users Addiction Research. 8: 311-326. DOI: 10.3109/16066350009009518  0.424
2000 Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals Journal of Clinical Microbiology. 38: 575-577. DOI: 10.1128/Jcm.38.2.575-577.2000  0.354
2000 Monterroso ER, Hamburger ME, Vlahov D, Des Jarlais DC, Ouellet LJ, Altice FL, Byers RH, Kerndt PR, Watters JK, Bowser BP, Fernando MD, Holmberg SD. Prevention of HIV Infection in Street-Recruited Injection Drug Users Jaids Journal of Acquired Immune Deficiency Syndromes. 25: 63-70. DOI: 10.1097/00126334-200009010-00009  0.505
2000 Tang AM, Smit E, Semba RD, Shah N, Lyles CM, Li D, Vlahov D. Improved Antioxidant Status Among HIV-Infected Injecting Drug Users on Potent Antiretroviral Therapy Journal of Acquired Immune Deficiency Syndromes. 23: 321-326. DOI: 10.1097/00126334-200004010-00006  0.436
2000 Vertefeuille J, Marx MA, Tun W, Huettner S, Strathdee SA, Vlahov D. Decline in self-reported high-risk injection-related behaviors among HIV-seropositive participants in the Baltimore needle exchange program Aids and Behavior. 4: 381-388. DOI: 10.1023/A:1026406623736  0.49
2000 Carrieri M, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART Drug and Alcohol Dependence. 60: 51-54. DOI: 10.1016/S0376-8716(00)80007-1  0.482
1999 Rich JD, Dickinson BP, Macalino G, Flanigan TP, Towe CW, Spaulding A, Vlahov D. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. Journal of Acquired Immune Deficiency Syndromes (1999). 22: 161-6. PMID 10843530 DOI: 10.1097/00126334-199910010-00008  0.442
1999 Greenberg B, Berkman A, Thomas R, Hoos D, Finkelstein R, Aste J, Vlahov D. Evaluating supervised HAART in late-stage HIV among drug users: A preliminary report Journal of Urban Health. 76: 468-480. PMID 10609596 DOI: 10.1007/Bf02351504  0.446
1999 Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France. American Journal of Public Health. 89: 1852-4. PMID 10589315 DOI: 10.2105/Ajph.89.12.1852  0.371
1999 Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer KH. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 29: 1145-50. PMID 10524955 DOI: 10.1086/313434  0.436
1999 Carneiro M, Yu XF, Lyles C, Templeton A, Weisstein AE, Safaeian M, Farzadegan H, Vlahov D, Markham RB. The effect of drug-injection behavior on genetic evolution of HIV-1. The Journal of Infectious Diseases. 180: 1025-32. PMID 10479127 DOI: 10.1086/315044  0.468
1999 Lyles CM, Dorrucci M, Vlahov D, Pezzotti P, Angarano G, Sinicco A, Alberici F, Alcorn TM, Vella S, Rezza G. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. The Journal of Infectious Diseases. 180: 1018-24. PMID 10479126 DOI: 10.1086/314980  0.35
1999 Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters. The Journal of Infectious Diseases. 180: 666-72. PMID 10438353 DOI: 10.1086/314967  0.389
1999 Garfein RS, Lyerla R, Jones TS, Nakashima AK, Monterroso ER, Vlahov D. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study". American Journal of Epidemiology. 150: 325-6. PMID 10430240 DOI: 10.1093/Oxfordjournals.Aje.A010009  0.483
1999 Comer JA, Tzianabos T, Flynn C, Vlahov D, Childs JE. Serologic evidence of rickettsialpox (Rickettsia akari) infection among intravenous drug users in inner-city Baltimore, Maryland. The American Journal of Tropical Medicine and Hygiene. 60: 894-8. PMID 10403316 DOI: 10.4269/Ajtmh.1999.60.894  0.362
1999 Carrieri MP, Moatti JP, Vlahov D, Obadia Y, Reynaud-Maurupt C, Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. Journal of Epidemiology and Community Health. 53: 4-8. PMID 10326045 DOI: 10.1136/Jech.53.1.4  0.504
1999 van Ameijden EJ, Krol A, Vlahov D, Flynn C, van Haastrecht HJ, Coutinho RA. Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison. Substance Use & Misuse. 34: 845-65. PMID 10227114 DOI: 10.3109/10826089909037245  0.369
1999 Rompalo AM, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg SD, Warren DL, Farzadegan H, Vlahov D, Smith DK. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 20: 448-54. PMID 10225226 DOI: 10.1097/00042560-199904150-00006  0.445
1999 Krol A, Flynn C, Vlahov D, Miedema F, Coutinho RA, van Ameijden EJ. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users. Drug and Alcohol Dependence. 54: 145-54. PMID 10217554 DOI: 10.1016/S0376-8716(98)00158-6  0.435
1999 Lyles CM, Graham NM, Astemborski J, Vlahov D, Margolick JB, Saah AJ, Farzadegan H. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. European Journal of Epidemiology. 15: 99-108. PMID 10204638 DOI: 10.1023/A:1007556327269  0.447
1999 Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. The Journal of Infectious Diseases. 179: 1297-300. PMID 10191241 DOI: 10.1086/314707  0.309
1999 Carneiro M, Fuller C, Doherty MC, Vlahov D. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old Drug and Alcohol Dependence. 54: 83-86. PMID 10101620 DOI: 10.1016/S0376-8716(98)00142-2  0.419
1999 Pezzotti P, Galai N, Vlahov D, Rezza G, Lyles CM, Astemborski J. Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 20: 275-82. PMID 10077177 DOI: 10.1097/00042560-199903010-00010  0.45
1999 Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (New York, N.Y.). 283: 1748-52. PMID 10073943 DOI: 10.1126/Science.283.5408.1748  0.351
1999 Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection Hepatology. 29: 908-914. PMID 10051497 DOI: 10.1002/Hep.510290311  0.304
1999 Junge B, Vlahov D, Riley E, Huettner S, Brown M, Beilenson P. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 39: 17-22. PMID 9990182 DOI: 10.1016/S1086-5802(16)30410-7  0.345
1999 Inglesby TV, Rai R, Astemborski J, Gruskin L, Nelson KE, Vlahov D, Thomas DL. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology (Baltimore, Md.). 29: 590-6. PMID 9918940 DOI: 10.1002/Hep.510290219  0.31
1999 Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group. The Journal of Allergy and Clinical Immunology. 103: 93-8. PMID 9893191 DOI: 10.1016/S0091-6749(99)70531-2  0.413
1998 Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (New York, N.Y.). 282: 1907-11. PMID 9836644 DOI: 10.1126/Science.282.5395.1907  0.377
1998 Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet (London, England). 352: 1510-4. PMID 9820299 DOI: 10.1016/S0140-6736(98)02372-1  0.387
1998 Lyles CM, Vlahov D, Farzadegan H, Astemborski J, Margolick JB, Masters BA, Schroeder J, Quinn TC. Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups Journal of Clinical Microbiology. 36: 3647-3652. PMID 9817889 DOI: 10.1128/Jcm.36.12.3647-3652.1998  0.394
1998 Latkin CA, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users Addiction. 93: 1191-1197. PMID 9813900 DOI: 10.1046/J.1360-0443.1998.93811917.X  0.451
1998 Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. Diversification of subtype e human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand Journal of Infectious Diseases. 178: 1507-1511. PMID 9780276 DOI: 10.1086/314441  0.448
1998 Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Proceedings of the National Academy of Sciences of the United States of America. 95: 12568-12573. PMID 9770526 DOI: 10.1073/Pnas.95.21.12568  0.336
1998 Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. Aids (London, England). 12: 1451-7. PMID 9727565 DOI: 10.1097/00002030-199812000-00006  0.302
1998 Valente TW, Foreman RK, Junge B, Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program Public Health Reports. 113: 90-96. PMID 9722814  0.353
1998 Vlahov D, Junge B. The role of needle exchange programs in HIV prevention Public Health Reports. 113: 75-80. PMID 9722812  0.402
1998 Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users Journal of the American Medical Association. 280: 544-546. PMID 9707145 DOI: 10.1001/Jama.280.6.544  0.481
1998 Zhang H, Flynn C, Nelson KE, Chen W, Kawalski R, Vlahov D. HIV/HTLV-II coinfection and CD4+ cell count controlling for plasma HIV viral load in injection drug users in Baltimore. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 18: 397-8. PMID 9704951 DOI: 10.1097/00042560-199808010-00018  0.447
1998 Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. The Journal of Infectious Diseases. 178: 388-96. PMID 9697718 DOI: 10.1086/515646  0.376
1998 Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 18: S133-8. PMID 9663636 DOI: 10.1097/00042560-199802001-00022  0.405
1998 Gleghorn AA, Gee G, Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 18: S89-93. PMID 9663630 DOI: 10.1097/00042560-199802001-00016  0.426
1998 Keyl PM, Gruskin L, Casano K, Montag H, Junge B, Vlahov D. Community support for needle exchange programs and pharmacy sale of syringes: a household survey in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. S82-8. PMID 9663629 DOI: 10.1097/00042560-199802001-00015  0.364
1998 Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18. PMID 9663618 DOI: 10.1097/00042560-199802001-00004  0.361
1998 Jones TS, Vlahov D. Use of sterile syringes and aseptic drug preparation are important components of HIV prevention among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 18: S1-5. PMID 9663616  0.381
1998 Donahoe RM, Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS Journal of Neuroimmunology. 83: 77-87. PMID 9610676 DOI: 10.1016/S0165-5728(97)00224-5  0.459
1998 Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Vitamin A supplementation and human immunodeficiency virus load in injection drug users. The Journal of Infectious Diseases. 177: 611-6. PMID 9498439 DOI: 10.1086/514235  0.412
1998 Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, ... ... Vlahov D, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science (New York, N.Y.). 279: 389-93. PMID 9430590 DOI: 10.1126/Science.279.5349.389  0.378
1998 Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Jama. 279: 35-40. PMID 9424041 DOI: 10.1001/Jama.279.1.35  0.465
1998 Latkin CA, Mandell W, Knowlton AR, Vlahov D, Hawkins W. Personal Network Correlates and Predictors of Homelessness for Injection Drug Users in Baltimore, Maryland Journal of Social Distress and the Homeless. 7: 263-278. DOI: 10.1023/A:1022943311679  0.435
1998 Vlahov D, Wientge D, Moore J, Flynn C, Schuman P, Schoenbaum E, Zierler S, Rompalo A, Sobel J, Klein R, Carpenter C, Mayer K, Smith D, Warren D, Duerr A, et al. Aids and Behavior. 2: 53-60. DOI: 10.1023/A:1022359307814  0.441
1997 Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, Beilenson P. Reductions in high-risk drug use behaviors among participants in the Baltimore Needle Exchange Program Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 16: 400-406. PMID 9420320 DOI: 10.1097/00042560-199712150-00014  0.356
1997 Alcabes P, Pezzotti P, Phillips AN, Rezza G, Vlahov D. Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression. American Journal of Epidemiology. 146: 543-51. PMID 9326431 DOI: 10.1093/Oxfordjournals.Aje.A009312  0.4
1997 Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 726-8. PMID 9314468 DOI: 10.1086/513757  0.416
1997 Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. The Journal of Infectious Diseases. 176: 586-92. PMID 9291303 DOI: 10.1086/514078  0.329
1997 Smith DK, Warren DL, Vlahov D, Schuman P, Stein MD, Greenberg BL, Holmberg SD. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. American Journal of Epidemiology. 146: 459-69. PMID 9290506 DOI: 10.1093/Oxfordjournals.Aje.A009299  0.482
1997 Lyles CM, Margolick JB, Astemborski J, Graham NM, Anthony JC, Hoover DR, Vlahov D. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users. Aids (London, England). 11: 1255-62. PMID 9256944 DOI: 10.1097/00002030-199710000-00009  0.695
1997 Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (New York, N.Y.). 277: 959-65. PMID 9252328 DOI: 10.1126/Science.277.5328.959  0.424
1997 Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NM. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. The Journal of Infectious Diseases. 176: 144-50. PMID 9207360 DOI: 10.1086/514016  0.356
1997 Guimarães MDC, Vlahov D, Castilho EA. Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil Archives of Internal Medicine. 157: 1362-1368. PMID 9201011 DOI: 10.1001/Archinte.1997.00440330102012  0.434
1997 Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea JM, Vlahov D, Muñoz A. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. International Journal of Std & Aids. 8: 225-8. PMID 9147154 DOI: 10.1258/0956462971919967  0.438
1997 Doherty MC, Garfein RS, Vlahov D, Junge B, Rathouz PJ, Galai N, Anthony JC, Beilenson P. Discarded needles do not increase soon after the opening of a needle exchange program. American Journal of Epidemiology. 145: 730-7. PMID 9125999 DOI: 10.1093/Aje/145.8.730  0.621
1997 Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal of Clinical Microbiology. 35: 1244-7. PMID 9114415 DOI: 10.1128/Jcm.35.5.1244-1247.1997  0.323
1997 McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 14: 355-60. PMID 9111478 DOI: 10.1097/00042560-199704010-00008  0.345
1997 Concha M, Selnes OA, Vlahov D, Nance-Sproson T, Updike M, Royal W, Palenicek J, McArthur JC. Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men Neuroepidemiology. 16: 78-85. PMID 9057169 DOI: 10.1159/000109674  0.408
1997 Selnes OA, Galai N, McArthur JC, Cohn S, Royal W, Esposito D, Vlahov D. HIV infection and cognition in intravenous drug users: Long-term follow-up Neurology. 48: 223-230. PMID 9008522 DOI: 10.1212/Wnl.48.1.223  0.441
1997 Semba RD, Farzadegan H, Vlahov D. Vitamin A levels and human immunodeficiency virus load in injection drug users Clinical and Diagnostic Laboratory Immunology. 4: 93-95. PMID 9008289 DOI: 10.1128/Cdli.4.1.93-95.1997  0.422
1997 Rezza G, Pizzuti R, De Campora E, De Masi S, Vlahov D. Tetanus and injections drug use: rediscovery of a neglected problem? European Journal of Epidemiology. 12: 655-6. PMID 8982630 DOI: 10.1007/Bf00499469  0.341
1997 Sagliocca L, Rezza G, Vlahov D, Baldassarre C, Siconolfi M, Nespoli M, Carriers P. A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids Addiction Research. 5: 137-144. DOI: 10.3109/16066359709005255  0.476
1997 Shah KV, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. Journal of Clinical Microbiology. 35: 517-519. DOI: 10.1128/Jcm.35.2.517-519.1997  0.348
1997 Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology. 35: 3274-3277. DOI: 10.1128/Jcm.35.12.3274-3277.1997  0.372
1997 Ahdieh L, Muñoz A, Cohn S, Daniel R, Solomon L, Vlahov D, Shah KV. HIV INFECTION AND ASSOCIATED IMMUNOSUPPRESSION ACCELERATES PROGRESSION OF HPV RELATED CERVICAL NEOPLASIA IN INJECTION DRUG USING WOMEN Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A19. DOI: 10.1097/00042560-199704010-00052  0.384
1997 Smith D, Hanson D, Graham N, Flynn M, Greenberg B, Sowell Ding A, Vlahov D. Nutritional status and its behavioral and clinical correlates in the hers cohort of HIV-infected and at-risk uninfected women Nutrition. 13: 270. DOI: 10.1016/S0899-9007(97)82630-5  0.395
1996 Latkin CA, Mandell W, Vlahov D. The relationship between risk networks' patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: A prospective study Drug and Alcohol Dependence. 42: 175-181. PMID 8912800 DOI: 10.1016/S0376-8716(96)01279-3  0.415
1996 Manoff SB, Vlahov D, Herskowitz A, Solomon L, Muñoz A, Cohn S, Willoughby SB, Nelson KE. Human immunodeficiency virus infection and infective endocarditis among injecting drug users Epidemiology. 7: 566-570. PMID 8899380 DOI: 10.1097/00001648-199611000-00001  0.508
1996 Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: Behavioral settings and personal network characteristics as correlates of needle sharing Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13: 273-280. PMID 8898673 DOI: 10.1097/00042560-199611010-00010  0.428
1996 Solomon L, Moore J, Gleghorn A, Astemborski J, Vlahov D. HIV testing behaviors in a population of inner-city women at high risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 13: 267-72. PMID 8898672 DOI: 10.1097/00042560-199611010-00009  0.417
1996 Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition (Burbank, Los Angeles County, Calif.). 12: 496-501. PMID 8878141 DOI: 10.1016/S0899-9007(96)91726-8  0.382
1996 Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The SAFE study American Journal of Community Psychology. 24: 341-364. PMID 8864208 DOI: 10.1007/Bf02512026  0.481
1996 Lukashov VV, Kuiken CL, Vlahov D, Coutinho RA, Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. Aids Research and Human Retroviruses. 12: 1179-83. PMID 8844022 DOI: 10.1089/Aid.1996.12.1179  0.379
1996 Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. The Journal of Infectious Diseases. 174: 690-5. PMID 8843204 DOI: 10.1093/Infdis/174.4.690  0.431
1996 Pezzotti P, Phillips AN, Dorrucci M, Lepri AC, Galai N, Vlahov D, Rezza G. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group. Bmj (Clinical Research Ed.). 313: 583-6. PMID 8806246 DOI: 10.1136/Bmj.313.7057.583  0.392
1996 Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF. Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. Journal of Virology. 70: 6947-54. PMID 8794338 DOI: 10.1128/Jvi.70.10.6947-6954.1996  0.333
1996 Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science (New York, N.Y.). 273: 1856-62. PMID 8791590 DOI: 10.1126/Science.273.5283.1856  0.424
1996 Crum RM, Galai N, Cohn S, Celentano DD, Vlahov D. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis. Alcoholism, Clinical and Experimental Research. 20: 364-71. PMID 8730231 DOI: 10.1111/J.1530-0277.1996.Tb01654.X  0.434
1996 Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. The Journal of Infectious Diseases. 174: 309-17. PMID 8699060 DOI: 10.1093/Infdis/174.2.309  0.443
1996 Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. The Journal of Infectious Diseases. 174: 299-308. PMID 8699059 DOI: 10.1093/Infdis/174.2.299  0.467
1996 Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses American Journal of Public Health. 86: 655-661. PMID 8629715 DOI: 10.2105/Ajph.86.5.655  0.43
1996 Levine OS, Vlahov D, Brookmeyer R, Cohn S, Nelson KE. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users Journal of Infectious Diseases. 173: 579-583. PMID 8627020 DOI: 10.1093/Infdis/173.3.579  0.461
1996 Galai N, Margolick JB, Astemborski J, Vlahov D. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-lnfected injection drug users Clinical Immunology and Immunopathology. 79: 134-141. PMID 8620619 DOI: 10.1006/Clin.1996.0060  0.437
1996 Zwahlen M, Vlahov D, Hoover DR. Re: "Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study" and "Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991". American Journal of Epidemiology. 143: 523-525. PMID 8610669 DOI: 10.1093/Oxfordjournals.Aje.A008775  0.41
1996 Shah SM, Shapshak P, Rivers JE, Stewart RV, Weatherby NL, Xin KQ, Page JB, Chitwood DD, Mash DC, Vlahov D, McCoy CB. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 11: 301-6. PMID 8603266 DOI: 10.1097/00042560-199603010-00010  0.429
1996 Galai N, Lepri AC, Vlahov D, Pezzotti P, Sinicco A, Rezza G. Temporal trends of initial CD4 cell counts following human immunodeficiency virus seroconversion in Italy, 1985-1992. The Human Immunodeficiency Virus Italian Seroconversion Study. American Journal of Epidemiology. 143: 278-82. PMID 8561162 DOI: 10.1093/Oxfordjournals.Aje.A008739  0.354
1996 Hoover DR, Doherty MC, Vlahov D, Miotti P. Incidence and risk factors for HIV-1 infection - A summary of what is known and the psychiatric relevance International Review of Psychiatry. 8: 137-148. DOI: 10.3109/09540269609046298  0.457
1995 Khabbaz RF, Ksiazek TG, Caiaffa WT, Rollin PE, Taylor E, Vlahov D. Seoul hantavirus seropositivity among injecting drug users in Baltimore. The Journal of Infectious Diseases. 170: 1636-7. PMID 7996013 DOI: 10.1093/Infdis/170.6.1636  0.398
1995 Roca J, Vlahov D, Borrell C, Jansa JM, Brugal T, Yazbeck H, Muñoz A. Geographic variation in HIV infection among injecting drug users with Barcelona. The International Journal of the Addictions. 30: 219-29. PMID 7759174 DOI: 10.3109/10826089509060744  0.504
1995 Semba RD, Caiaffa WT, Graham NMH, Cohn S, Vlahov D. Vitamin a deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users Journal of Infectious Diseases. 171: 1196-1202. PMID 7751694 DOI: 10.1093/Infdis/171.5.1196  0.417
1995 Sorkin JD, Bolton PA, Greenblatt J, Sithisarankul P, Vlahov D, Graham NM. Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology (Cambridge, Mass.). 6: 172-7. PMID 7742405 DOI: 10.1097/00001648-199503000-00015  0.488
1995 Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. The Journal of Infectious Diseases. 171: 797-804. PMID 7706805 DOI: 10.1093/Infdis/171.4.797  0.423
1995 Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, Knowlton A. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS Drug and Alcohol Dependence. 38: 1-9. PMID 7648991 DOI: 10.1016/0376-8716(94)01082-V  0.401
1995 Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 10: 97-103. PMID 7648292 DOI: 10.1097/00042560-199509000-00014  0.494
1995 Vlahov D. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 10: 71-72. PMID 7648287  0.393
1995 Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis b virus in a population of injecting drug users: Association with drug injection patterns American Journal of Epidemiology. 142: 331-341. PMID 7631637 DOI: 10.1093/Oxfordjournals.Aje.A117639  0.428
1995 Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Correlates of hepatitis C virus infections among injection drug users. Medicine. 74: 212-20. PMID 7623656 DOI: 10.1097/00005792-199507000-00005  0.392
1995 Concha M, Selnes OA, McArthur JC, Nance-Sproson T, Updike ML, Royal W, Solomon L, Vlahov D. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users International Journal of the Addictions. 30: 823-841. PMID 7558472 DOI: 10.3109/10826089509067009  0.356
1995 Serpelloni G, Vlahov D, Mazzi M, Rezza G. Interest in HIV vaccines among Italian injection drug users [1] Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 10: 206-207. PMID 7552488  0.331
1995 Latkin CA, Mandell W, Vlahov D, Knowlton AR, Oziemkowska M, Celentano DD. Self-reported reasons for needle sharing and not carrying bleach among injection drug users in baltimore, maryland Journal of Drug Issues. 25: 865-870. DOI: 10.1177/002204269502500413  0.443
1995 Solomon L, Vlahov D, Astemborski J, Galai N, Graham NM, Nelson KE. Factors Associated with Initiation of Zidovudine in a Cohort of Injection Drug Users Journal of Drug Issues. 25: 225-233. DOI: 10.1177/002204269502500115  0.454
1995 Harrison K, Vlahov D, Jones K, Charron K, Clements ML. Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10: 386???390. DOI: 10.1097/00042560-199511000-00012  0.459
1995 Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, Vlahov D. Recent Infection with Human Immunodeficiency Virus and Possible Rapid Loss of CD4 T Lymphocytes Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9: 291???296. DOI: 10.1097/00042560-199507000-00011  0.408
1995 Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and Risk Factors for Human T-Lymphotropic Virus Type II Seroconversion Among Injecting Drug Users in Baltimore, Maryland, U.S.A Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 9: 89???96. DOI: 10.1097/00042560-199505010-00013  0.371
1995 Galai N, Vlahov D, Margolick JB, Chen K, Graham NMH, Munoz A. Changes in Markers of Disease Progression in HIV-1 Seroconverters Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 8: 66???82. DOI: 10.1097/00042560-199501000-00011  0.481
1995 Latkin C, Mandell W, Vlahov D, Knowlton A, Oziemkowska M, Celentano D. Personal network characteristics as antecedents to needle-sharing and shooting gallery attendance Social Networks. 17: 219-228. DOI: 10.1016/0378-8733(95)00263-N  0.389
1994 Vlahov D, Ryan C, Solomon L, Cohn S, Holt MR, Akhter MN. A pilot syringe exchange program in Washington, DC. American Journal of Public Health. 84: 303-4. PMID 8296961 DOI: 10.2105/Ajph.84.2.303  0.348
1994 Vlahov D, Astemborski J, Solomon L, Nelson KE. Field effectiveness of needle disinfection among injecting drug users Journal of Acquired Immune Deficiency Syndromes. 7: 760-766. PMID 8207660  0.406
1994 Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. Correlates of needle sharing among injection drug users American Journal of Public Health. 84: 920-923. PMID 8203687 DOI: 10.2105/Ajph.84.6.920  0.462
1994 Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. American Journal of Epidemiology. 139: 918-26. PMID 8166142 DOI: 10.1093/Oxfordjournals.Aje.A117098  0.44
1994 Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users American Journal of Public Health. 84: 382-387. PMID 8129052 DOI: 10.2105/Ajph.84.3.382  0.5
1994 Schütz CG, Vlahov D, Anthony JC, Graham NM. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. Journal of Clinical Epidemiology. 47: 191-5. PMID 8113828 DOI: 10.1016/0895-4356(94)90024-8  0.668
1994 Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D. The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland Sexually Transmitted Diseases. 21: 161-167. PMID 8073344 DOI: 10.1097/00007435-199405000-00006  0.38
1994 Vlahov D. HIV seroconversion studies among intravenous drug users Aids. 8: 263-265. PMID 8043233 DOI: 10.1097/00002030-199402000-00016  0.49
1994 Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, Lelli V, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. Aids (London, England). 8: 345-50. PMID 8031512 DOI: 10.1097/00002030-199403000-00008  0.471
1994 Chilcoat HD, Muñoz A, Vlahov D, Anthony JC. Low power? Use two-dimensional confidence regions as a graphical method for depicting uncertainty. Drug and Alcohol Dependence. 36: 39-48. PMID 7988358 DOI: 10.1016/0376-8716(94)90008-6  0.579
1994 Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, Muñoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. American Journal of Respiratory and Critical Care Medicine. 150: 1493-8. PMID 7952605 DOI: 10.1164/Ajrccm.150.6.7952605  0.444
1994 Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL. Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus Journal of the American College of Cardiology. 24: 1025-1032. PMID 7930193 DOI: 10.1016/0735-1097(94)90865-6  0.375
1994 Vlahov D, Muñoz A, Solomon L, Astemborski J, Lindsay A, Anderson J, Galai N, Nelson KE. Comparison of clinical manifestations of HIV infection between male and female injecting drug users. Aids (London, England). 8: 819-23. PMID 7916193 DOI: 10.1097/00002030-199406000-00015  0.446
1994 Alcabes P, Muñoz A, Vlahov D, Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users Annals of Epidemiology. 4: 17-26. PMID 7911376 DOI: 10.1016/1047-2797(94)90038-8  0.489
1994 Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: Behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland American Journal of Community Psychology. 22: 415-430. PMID 7879749 DOI: 10.1007/Bf02506873  0.461
1994 Vlahov D. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda Aids Research and Human Retroviruses. 10. PMID 7865324  0.403
1994 Schütz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug and Alcohol Dependence. 36: 129-38. PMID 7851280 DOI: 10.1016/0376-8716(94)90095-7  0.657
1994 Gershon RRM, Curbow B, Kelen G, Celantano D, Lears K, Vlahov D. Correlates of attitudes concerning human immunodeficiency virus and acquired immunodeficiency syndrome among hospital workers Ajic: American Journal of Infection Control. 22: 293-299. PMID 7847636 DOI: 10.1016/0196-6553(94)90016-7  0.382
1994 Celentano DD, Munoz A, Cohn S, Nelson KE, Vlahov D. Drug-related behavior change for HIV transmission among American injection drug users Addiction. 89: 1309-1317. PMID 7804092 DOI: 10.1111/J.1360-0443.1994.Tb03310.X  0.472
1994 Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis b virus infections among injecting drug users: Seroprevalence, risk factors, and viral interactions Epidemiologic Reviews. 16: 418-436. PMID 7713187 DOI: 10.1093/Oxfordjournals.Epirev.A036161  0.38
1994 Mandell W, Vlahov D, Latkin CA, Carran D, Oziemkowska MJ, Reedt L. Changes in HIV Risk Behaviors among Counseled Injecting Drug Users Journal of Drug Issues. 24: 555-567. DOI: 10.1177/002204269402400314  0.434
1993 Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction (Abingdon, England). 88: 517-26. PMID 8485429 DOI: 10.1111/J.1360-0443.1993.Tb02058.X  0.666
1993 Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson KE. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users. American Journal of Epidemiology. 137: 892-8. PMID 8484380 DOI: 10.1093/Oxfordjournals.Aje.A116750  0.491
1993 Strickler HD, Blanchard JF, Vlahov D, Taylor E, Muñoz A, Nelson KE, Margolick JB. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users. Aids (London, England). 7: 361-7. PMID 8471199 DOI: 10.1097/00002030-199303000-00009  0.486
1993 Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection The American Journal of Cardiology. 71: 955-958. PMID 8465788 DOI: 10.1016/0002-9149(93)90913-W  0.372
1993 Willoughby SB, Vlahov D, Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users The American Journal of Cardiology. 71: 446-447. PMID 8430637 DOI: 10.1016/0002-9149(93)90451-H  0.474
1993 Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users. The Journal of Infectious Diseases. 168: 327-31. PMID 8335969 DOI: 10.1093/Infdis/168.2.327  0.432
1993 Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland European Journal of Epidemiology. 9: 566-569. PMID 8307145 DOI: 10.1007/Bf00209538  0.303
1993 Caiaffa WT, Graham NMH, Vlahov D. Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection American Journal of Epidemiology. 138: 909-922. PMID 8256779 DOI: 10.1093/Oxfordjournals.Aje.A116812  0.392
1993 Watters JK, Jones TS, Shapshak P, McCoy CB, Flynn N, Gleghorn A, Vlahov D. Household bleach as disinfectant for use by injecting drug users. Lancet (London, England). 342: 742-3. PMID 8103844 DOI: 10.1016/0140-6736(93)91735-5  0.397
1993 Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men Archives of Internal Medicine. 153: 1806-1812. PMID 8101438 DOI: 10.1001/Archinte.1993.00410150094009  0.459
1993 Concha M, Graham NM, Muñoz A, Vlahov D, Royal W, Updike M, Nance-Sproson T, Selnes OA, McArthur JC. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. American Journal of Epidemiology. 136: 1338-48. PMID 1362630 DOI: 10.1093/Oxfordjournals.Aje.A116446  0.474
1993 Jason J, Solomon L, Celentano DD, Vlahov D. Potential use of mass media to reach urban intravenous drug users with AIDS prevention messages Substance Use and Misuse. 28: 837-851. DOI: 10.3109/10826089309039660  0.388
1993 Palenicek J, Nelson KE, Vlahov D. HIV disease symptoms in intravenous drug users and homosexual men compared Journal of the American Osteopathic Association. 93: 912.  0.351
1992 Royal W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, Vlahov D, Cornblath DR, McArthur JC. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology. 41: 1905-10. PMID 1745346 DOI: 10.1212/Wnl.41.12.1905  0.472
1992 Vlahov D. HIV-1 infection in the correctional setting Nida Research Monograph. 118: 51-61. PMID 1620226 DOI: 10.1177/088740349000400402  0.46
1992 Latkin CA, Vlahov D, Anthony JC, Cohn S, Mandell W, Nelson KE. Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland. The International Journal of the Addictions. 27: 717-25. PMID 1612823 DOI: 10.3109/10826089209068763  0.688
1992 Smith AM, Vlahov D, Menon AS, Anthony JC. Terminology for drug injection practices among intravenous drug users in Baltimore. The International Journal of the Addictions. 27: 435-53. PMID 1563894 DOI: 10.3109/10826089209068752  0.668
1992 Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviors among intravenous drug users. British Journal of Addiction. 87: 417-28. PMID 1559040 DOI: 10.1111/J.1360-0443.1992.Tb01942.X  0.695
1992 Smith MD, Celentano DD, Solomon L, Astemborski J, Vlahov D. Knowledge of therapeutics for human immunodeficiency virus infection among intravenous drug users Journal of Infectious Diseases. 166: 685-686. PMID 1500759 DOI: 10.1093/Infdis/166.3.685  0.396
1992 Selnes OA, McArthur JC, Royal W, Updike ML, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. Hiv–1 infection and intravenous drug use: Longitudinal neuropsychological evaluation of asymptomatic subjects Neurology. 42: 1924-1930. PMID 1407574 DOI: 10.1212/Wnl.42.10.1924  0.495
1992 Alcabes P, Vlahov D, Anthony JC. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? British Journal of Addiction. 87: 47-54. PMID 1311973 DOI: 10.1111/J.1360-0443.1992.Tb01899.X  0.692
1992 Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. The Journal of Nervous and Mental Disease. 180: 48-54. PMID 1311371 DOI: 10.1097/00005053-199201000-00010  0.655
1992 Chaisson RE, Taylor E, Margolick JB, Mu??oz A, Solomon L, Cohn S, Nelson KE, Vlahov D. Immune Serum Markers and CD4 Cell Counts in HIV-Infected Intravenous Drug Users Jaids Journal of Acquired Immune Deficiency Syndromes. 5: 456???460. DOI: 10.1097/00126334-199205000-00004  0.327
1992 Behrendt C, Clark JP, Kendig N, Vlahov D. Hiv infection and aids among u.s. prison inmates Journal of Crime and Justice. 15: 173-186. DOI: 10.1080/0735648X.1992.9721458  0.456
1992 Nelson KE, Vlahov D, Anthony JC, Solomon L. In Reply Jama: the Journal of the American Medical Association. 267: 1340-1341. DOI: 10.1001/Jama.1992.03480100046022  0.657
1991 Samuels JF, Vlahov D, Anthony JC, Solomon L, Celentano DD. The practice of 'frontloading' among intravenous drug users: association with HIV-antibody. Aids (London, England). 5: 343. PMID 2059379  0.655
1991 Vlahov D, Anthony JC, Celentano D, Solomon L, Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. The American Journal of Drug and Alcohol Abuse. 17: 39-48. PMID 2038982 DOI: 10.3109/00952999108992808  0.662
1991 Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Muñoz A. Prevalence of antibody to HIV-1 among entrants to US correctional facilities. Jama. 265: 1129-32. PMID 1995998 DOI: 10.1001/Jama.1991.03460090077036  0.385
1991 Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health. 81: 1291-5. PMID 1928528 DOI: 10.2105/Ajph.81.10.1291  0.671
1991 Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus American Journal of Public Health. 81: 1285-1290. PMID 1928527 DOI: 10.2105/Ajph.81.10.1285  0.473
1991 Nelson KE, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony JC. Human immunodeficiency virus infection in diabetic intravenous drug users. Jama. 266: 2259-61. PMID 1920726 DOI: 10.1001/Jama.1991.03470160091038  0.666
1991 Nelson KE, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony JC, Hook EW. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). The Journal of Infectious Diseases. 164: 457-63. PMID 1869836 DOI: 10.1093/Infdis/164.3.457  0.465
1991 Vlahov D, Muñoz A, Celentano DD, Cohn S, Anthony JC, Chilcoat H, Nelson KE. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland. Epidemiology (Cambridge, Mass.). 2: 444-6. PMID 1790197 DOI: 10.1097/00001648-199111000-00010  0.689
1991 Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. American Journal of Epidemiology. 134: 1175-89. PMID 1746528 DOI: 10.1093/Oxfordjournals.Aje.A116021  0.686
1991 Donahue JG, Nelson KE, Muñoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, Cohn S, Odaka NJ, Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology. 134: 1206-11. PMID 1720924 DOI: 10.1093/Oxfordjournals.Aje.A116023  0.395
1991 Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NM, Schwartz DH, Lucas AH, Chaisson RE. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. The New England Journal of Medicine. 325: 1837-42. PMID 1683682 DOI: 10.1056/Nejm199112263252603  0.311
1991 Vlahov D, Anthony JC, Muñoz A, Margolick J, Nelson KE, Celentano DD, Solomon L, Polk BF. The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods Journal of Drug Issues. 21: 759-776. DOI: 10.1177/002204269102100406  0.708
1991 Anthony JC, Vlahov D, Celentano DD, Menon A, Margolick JB, Cohn S, Nelson KE, Polk BF. Self-Report Interview Data for a Study of HIV-1 Infection among Intravenous Drug Users: Description of Methods and Preliminary Evidence on Validity Journal of Drug Issues. 21: 739-757. DOI: 10.1177/002204269102100405  0.702
1991 Celentano DD, Vlahov D, Menon AS, Polk BF. Hiv Knowledge and Attitudes among Intravenous Drug Users: Comparisons to the U.S. Population and by Drug Use Behaviors Journal of Drug Issues. 21: 635-649. DOI: 10.1177/002204269102100311  0.5
1991 Zimmerman SE, Martin R, Vlahov D. Aids knowledge and risk perceptions among Pennsylvania prisoners Journal of Criminal Justice. 19: 239-256. DOI: 10.1016/0047-2352(91)90003-E  0.31
1990 Vlahov D, Muñoz A, Brewer F, Taylor E, Canner C, Polk BF. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. Aids (London, England). 4: 345-50. PMID 2350455 DOI: 10.1097/00002030-199004000-00010  0.415
1990 Tomas JM, Vlahov D, Anthony JC. Association between intravenous drug use and early misbehavior Drug and Alcohol Dependence. 25: 79-89. PMID 2323313 DOI: 10.1016/0376-8716(90)90145-5  0.67
1990 Gershon’ RM, Vlahov D, Nelson’ KE. HIV infection risk to nonhealth-care workers American Industrial Hygiene Association Journal. 51: A-807-A-809. PMID 2270827 DOI: 10.1080/15298669091370329  0.416
1990 Vlahov D, Muñoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology. 132: 847-56. PMID 2239899 DOI: 10.1093/Oxfordjournals.Aje.A115727  0.714
1990 Gershon RRM, Vlahov D, Nelson KE. The risk of transmission of HIV-1 through non-percutaneous, non-sexual modes - A review Aids. 4: 645-650. PMID 2204358 DOI: 10.1097/00002030-199007000-00006  0.336
1990 Salive ME, Vlahov D, Fordham Brewer T. Coinfection with tuberculosis and HIV-1 in male prison inmates Public Health Reports. 105: 307-310. PMID 2113691  0.312
1990 Vlahov D, Lee H, Taylor E, Canavaggio M, Canner C, Burczak J, Saah AJ. Antibody to Human T-Lymphotropic Virus Type I/II (HTLV-I/II) Among Male Inmates Entering Maryland Prisons Jaids Journal of Acquired Immune Deficiency Syndromes. 3: 531???535. DOI: 10.1097/00126334-199003050-00010  0.344
1990 Celentano DD, Brewer TF, Sonnega J, Vlahov D. Maryland inmates' knowledge of HIV-1 transmission and prevention; a comparison with the U.S. general population Journal of Prison and Jail Health. 9: 45-54.  0.343
1989 Brewer TF, Vlahov D, Taylor E, Hall D, Munoz A, Polk BF. Transmission of HIV-1 within a statewide prison system. Aids (London, England). 2: 363-7. PMID 3146264 DOI: 10.1097/00002030-198810000-00005  0.407
1989 Wabwire-Mangen F, Shiff CJ, Vlahov D, Kline R, Serwadda D, Sewankambo NK, Mugerwa RD, Quinn TC. Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. The American Journal of Tropical Medicine and Hygiene. 41: 504-11. PMID 2683820 DOI: 10.4269/Ajtmh.1989.41.504  0.402
1989 Vlahov D. AIDS: Overview, immunology, virology, and informational needs Seminars in Oncology Nursing. 5: 227-235. PMID 2682878 DOI: 10.1016/0749-2081(89)90002-8  0.397
1989 Novick DM, Trigg HL, Des Jarlais DC, Friedman SR, Vlahov D, Kreek MJ. Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City Journal of Medical Virology. 29: 181-185. PMID 2614398 DOI: 10.1002/Jmv.1890290307  0.483
1989 Wabwire-Mangen F, Serwadda D, Sewankambo NK, Mugerwa RD, Shiff CJ, Vlahov D, Heyward WL, Quinn TC. Further experience with the World Health Organization clinical case definition for AIDS in Uganda. Aids (London, England). 3: 462-3. PMID 2504252 DOI: 10.1097/00002030-198907000-00013  0.359
1988 Vlahov D, Polk F. Perspectives on infection with HIV-1 among intravenous drug users Psychopharmacology Bulletin. 24: 325-329. PMID 3153487  0.391
Show low-probability matches.